Arbaclofen in Children and Adolescents With ASD

Clinical trial NCT03682978 · COMPLETED

Trial details

NCT number: NCT03682978
Sponsor: Celso Arango, MD, PhD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2019-09-19
Primary completion: 2023-01-27
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.